The concept of searching for cancer drugs through synthetic lethality seems to be more rewarding when either the assay (FOXO1a in PTEN−/−) or the potential target gene (mTOR in PTEN−/−) can be decided upon based on data mining and prior knowledge of the normal and tumourigenic biological system. The gene discussed is FOXO1; the disease is cancer.